4.7 (728) In stock
Despite recent acquisitions and a demerger, the GSK share price has suffered in the face of an ongoing legal battle. Still, analysts remain bullish on its long-term potential.
Adiponectin Reverses β-Cell Damage and Impaired Insulin Secretion
GlaxoSmithKline: Back To The Drawing Board (NYSE:GSK)
Wage increase and inflation pressure
Leading company in comparison with leading innovative company
Completion of GSK Share Consolidation
Frontiers The role of enriched environment in neural development
Living on the edge: Patients groan as lifesaving drugs prices soar
Top trends in South Korean grocery in 2023
Cells, Free Full-Text
HowToRaiseRequest - GrantsAndDonations
Yarn price eases after big jump
